Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis
2019
Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
41
References
37
Citations
NaN
KQI